Suzanne Kennedy, Ph.D. Email & Phone Number

Austin, Tx, Us

Austin, Tx, Us

Austin, Tx, Us

New York City Area, Ny, Us

■ Locked 6 deals with leading pharma giants, closing contracts in the multi-millions.■ Launched game-changing partnership, with market reach of ~100M patients nationwide, massively elevating credibility and market presence.■ Initiated and sealed a significant partnership deal in just 3 months set to skyrocket customer base 20-30X and contributing to company positioning for series A financing.■ Leveraged time and resources 100X over by shifting business development strategy from piecemeal approach to strategic MSO relationships opening the doors to 100s of doctors. ■ In under 2 years, took company from relatively unknown to 6X pharma companies under contract for trials. ■ Boosted corporate LinkedIn and online presence, drawing new interest and claiming space in pharma trials.■ Guided the organization through explosive growth and pivotal development as 5th employee of a booming startup.■ Through diligent effort and strategic partnerships, significantly advanced the company's position in the market, contributing to its potential for a successful Series A funding round.

■ Serving as the scientific expert for groundbreaking microbiome-safe anti-acne skincare technology, presenting to executives for potential partnerships with industry giants like Estée Lauder and Guthy-Renker.■ Pivotal in strategizing for a pre-revenue skincare startup targeting global markets, showcasing biotechnology and strategic planning expertise.■ Bridged gap between science and business strategy, enabling entrance to billion dollar plus global market.

Houston, Texas, Us

■ Without any prior nutrition training, crash learned and formulated bespoke nutrition solutions for cystic fibrosis and cancer patients, monetizing a new novel lipid technology.■ Within days of formulating market appropriate website messaging, opened relationship with a global leader in medical nutrition and demonstrated clinical trial data and application of new technology culminating in $30M+ licensing deal.■ Developed licensing deals that elevated company profile and contributed to a 7-figure funding round.■ Identified new markets for technology application across veterinary nutrition, skin care, and antiviral/antimicrobial treatments, leveraging unique lipid properties to combat disease.■ Formulated an industry leading technology and forged strategic partnership with major animal health market player; secured and managed co-development of a project that drove exclusive pet food agreement.■ Led market push to parlay technology into innovative skincare treatment, establishing key partnership with a global CPG giant headquartered in the UK.■ Catalyzed licensing deals worth $30-100M+ in human nutrition, skincare, veterinary nutrition and cannabinoid delivery, doubling the company valuation.

Former title includes: Associate Director of Corporate Development.■ Investigated new targets and built pipeline and expansion strategy for clinical stage oncology therapeutics company.■ Sourced partners for out-licensing of antisense DNA RNAi therapeutic platform.■ Built shareholder value by demonstrating expansion into high potential areas for hard to treat cancers.■ Managed construction and launch of cutting-edge R&D facility, supercharging innovation engine.■ Established and led partnership with MD Anderson Cancer Center for pre-clinical validation of new antisense DNA gene target for pancreatic cancer.■ Sourced and landed a sponsored research agreement with Thomas Jefferson University to validate the DNAbilize technology for antisense DNA glioblastoma treatment.■ Unleashed novel Stat3 gene target, diversifying drug portfolio’s high-potential treatments.■ Communication acumen drove management of IP portfolio and communications between company, attorneys, IR firm, press writers, and patent discussions. ■ Authored a compelling business case for a major CPRIT grant, showcasing strategic insight and competitive positioning in cancer research.

Houston, Texas, Us

■ Secured $50K grant innovating pancreatic cancer screening, showcasing commitment to advancing medical research.■ Forged pivotal MD Anderson alliance, setting groundbreaking stage for pancreatic cancer and type 2 diabetes research.■ Thrived in challenging lab setting, while mentoring PhD students to success.

■ Launched 30+ new products in just 4.5 years, breaking the prior 2-year innovation drought.■ Contributed to realizing 25% YOY growth as compared to the 4-6% industry average at the time. ■ Drove 400%+ revenue growth, broke through prior revenue plateaus, and ultimately positioned company for purchase in a $66.9M acquisition bundle. ■ Fostered key collaborations and presented globally, positioning the company as a molecular biology leader.■ Led a scientific team developing products for DNA and RNA isolation from samples including microbes, plants, human cells and blood, tissues, soil, contaminated water, biofilms and stool. ■ Expanded into protein isolation from soil as a major development.■ Directed research and proof of concept for 2 patents, enhanced company's intellectual property, and drove unparalleled competitive edge.■ Co-authored 5 publications, 2 books, and numerous global presentations contributing to company's selection for major microbiome projects and boosting international recognition.■ Ideated and licensed revolutionary preservation product, cementing status as an industry innovator.■ Overcame lack of expertise or credibility in a crowded market and became known as the global leader for microbiome discovery and the official product for the Soil Microbiome Project and Human Microbiome Project.

Waltham, Ma, Us

■ Clinched #1 spot among 50 global product managers with standout product leadership and market growth strategies.■ Learned from $1.2B company how to bring products to market, from R&D to QC all the way through manufacturing and shipping. ■ Directed and grew 6 product lines encompassing 27 different products, with 7 new product launches in just 9 months.■ Drove 87% YOY growth across a wide DNA isolation product spectrum. ■ Built company’s first viral RNA isolation kit with sales beating projections by outstanding 300%, overpowering legacy US market leader.

Ph.D., Microbiology/Immunology

Bs, Microbiology